Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
6.41
-0.06 (-0.93%)
At close: Sep 25, 2026
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $35.52 million as of September 25, 2026. Its market cap has increased by 879.57% in one year.
Market Cap
35.52M
Enterprise Value
33.81M
Revenue
36.14M
Ranking
n/a
PE Ratio
1.41
Stock Price
$6.41
ChartMarket Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 35.52M, a decrease of -84.00%. That is a compound annual growth rate of -6.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 35.52M | 552.05% |
| Dec 31, 2025 | 5.45M | -54.11% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Global Cord Blood | 127.35M |
| Bioqual | 29.52M |
| Longduoduo Company | 15.31M |
| Psychemedics | 15.25M |
| Aspira Women's Health | 12.12M |
| iMD Companies | 3.05M |
| Stella Diagnostics | 2.43M |
| IDenta | 1.35M |